FDA: Single-agent inhalers higher risk of asthma attacks

The Food and Drug Administration says a combination of treatments is key for controlling asthma in children.

The FDA analyzed children using inhalers with or without drugs to treat the condition long-term and found those using only single-agent inhalers have a higher risk of attacks.

The risk decreases if inhalers are used along with corticosteroids because the inhalers only control airway spasms during an attack.

Other drugs are needed to treat the inflammation that blocks those airways.